Cannabis pills could be key to fighting opioid relapse
NCT ID NCT07148206
Summary
This study is testing whether two FDA-approved cannabis-based medications, dronabinol (THC) and Epidiolex (CBD), can help people with opioid addiction stay in treatment and reduce their opioid use. It focuses on people who have recently started buprenorphine, a standard addiction medicine, but are still struggling with withdrawal symptoms or cravings. The goal is to see if adding these pills for 8 weeks improves treatment success and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Health System (Montefiore) Buprenorphine Treatment Network
The Bronx, New York, 10467, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.